Findings hold implications for screening and potential nonsurgical therapy
Effect on gut microbiome emerges as another benefit of statin therapy
TMAO pathway impacts infarct size and functional impairment in preclinical stroke models
Metabolite proves predictive in a large prospective cohort of apparently healthy subjects
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Hazen group to pursue research programs in atherosclerosis, thrombosis, obesity
Two new studies add insights and home in on therapeutic targets
Mouse study shows most potent therapeutic ‘drugging’ of microbiome to date
Study finds strong prognostic value even in patients with negative baseline troponin T
Gut microbe-dependent metabolite linked to another cardiovascular condition
Study raises prospect of new mechanism for preventing thrombotic events